Treatment of pulmonary fibrosis in one convalescent patient with corona virus disease 2019 by oral traditional Chinese medicine decoction: A case report / 中西医结合学报
Journal of Integrative Medicine
; (12): 185-190, 2021.
Article
在 En
| WPRIM
| ID: wpr-881006
Responsible library:
WPRO
ABSTRACT
After one-month of oral treatment with traditional Chinese medicine decoction, without using other drugs, the lung inflammatory exudate, pulmonary fibrosis and quality of life of a 61-year-old female patient with corona virus disease 2019 (COVID-19) were significantly improved. No recurrence or deterioration of the patient's condition was found within seven weeks of treatment and follow-up, and no adverse events occurred, indicating that oral Chinese medicine decoction was able to improve the pulmonary inflammation and fibrosis in a patient recovering from COVID-19, but further research is still needed.
Key words
全文:
1
索引:
WPRIM
主要主题:
Pulmonary Fibrosis
/
Drugs, Chinese Herbal
/
Administration, Oral
/
Magnoliopsida
/
Exudates and Transudates
/
SARS-CoV-2
/
COVID-19
/
Inflammation
/
Lung
/
Medicine, Chinese Traditional
研究类型:
Diagnostic_studies
限制:
Female
/
Humans
语言:
En
期刊:
Journal of Integrative Medicine
年:
2021
类型:
Article